Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Clinical Oncology 6, 375 (1 July 2009) | doi:10.1038/nrclinonc.2009.77
Maintenance rituximab prolongs PFS
Abstract
Hochster, H. et al. Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized phase III ECOG1496 study. J. Clin.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
